Assessment of Induction Antithymocyte Globulin Dose Reduction on Outcomes of De Novo Belatacept Immunosuppression in Kidney Transplant Recipients at Risk for Delayed Graft Function

被引：0
|
作者：
Ali, M. [1 ]
Wynd, M. A. [1 ]
Patel, A. [2 ]
Ahmed, V. [2 ]
Serur, D. [2 ]
Goldstein, M. J. [2 ]
机构：
[1] Hackensack Univ, Med Ctr, Pharm, Hackensack, NJ USA
[2] Hackensack Univ, Med Ctr, Organ Transplant, Hackensack, NJ USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B211
引用
收藏
页码：S849 / S850
页数：2
相关论文
共 50 条
  • [1] Reduced Dose Rabbit Antithymocyte Globulin Induction for Kidney Transplant Recipients with Delayed Graft Function
    Snyder, Heather
    Duhart, Benjamin, Jr.
    Krauss, Amy
    Eason, James D.
    Rao, Vinaya
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 80 - 80
  • [2] Comparison of De Novo Sirolimus and Tacrolimus Based Immunosuppression in African American Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction
    Duhart, B., Jr.
    Centeno, A.
    Krauss, A.
    Patel, S.
    Nezakatgoo, N.
    Eason, J.
    Rao, V.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 305 - 305
  • [3] Infectious Complications and Leukopenia Following Alemtuzumab or Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients
    Khamash, H.
    Mannon, R.
    Hanaway, M.
    Gaston, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 482 - 482
  • [4] Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft
    Grinyo, JM
    Gil-Vernet, S
    Seron, D
    Hueso, M
    Fulladosa, X
    Cruzado, JM
    Moreso, F
    Fernandez, A
    Torras, J
    Riera, L
    Castelao, AM
    Alsina, J
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) : 2601 - 2604
  • [5] Outcomes of De Novo Belatacept-Based Immunosuppression in Recipients of Kidneys at High Risk for Delayed Graft Function in the Setting of Lymphocyte Depleting Immune Modulation
    Shertel, T. L.
    Wynd, M. A.
    Pereiras, M. A.
    McKeen, J. T.
    Yushkov, Y. Y.
    Schleich, B. R.
    Geatrakas, S. E.
    Patel, A.
    Goldstein, M. J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 925 - 925
  • [6] Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft Function
    Vu, Van Anh
    Bhayana, Suverta
    Sweiss, Helen
    Castro, Nohely
    Hall, Reed
    Nelson, Joelle
    [J]. PROGRESS IN TRANSPLANTATION, 2024, 34 (1-2) : 47 - 52
  • [7] EFFICACY AND SAFETY OF OUTPATIENT RABBIT-ANTITHYMOCYTE GLOBULIN INDUCTION IN DE-NOVO KIDNEY TRANSPLANT RECIPIENTS
    Sparkes, Tracy M.
    Trofe-Clark, Jennifer
    Reese, Peter P.
    Jakobowski, Diane
    Goral, Simin
    Doll, Stacey L.
    Abt, Peter L.
    Sawinski, Deirdre
    MBloom, Roy D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 509 - 510
  • [8] Lower Dose Anti-Thymocyte Globulin Induction in Kidney Transplant Recipients with Slow or Delayed Graft Function is Not Associated with Higher Risk of Rejection or De Novo Donor-Specific Antibodies
    Yap, Y.
    Misel, M.
    Khan, A.
    Lichvar, A.
    Fabbri, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S835 - S835
  • [9] Delayed Graft Function Is Reduced With Antithymocyte Globulin Induction in Pediatric Kidney Transplantation
    Vilalta, R.
    Lara, E.
    Madrid, A.
    Chocron, S.
    Vazquez, A.
    Casquero, A.
    Nieto, J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2373 - 2375
  • [10] Alemtuzumab versus Antithymocyte Globulin Induction Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Brueckner, A.
    Yanqui, E.
    Truong, C.
    Baliga, R.
    Bowman, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 823 - 823
12345